
1. plos one. 2016 jan 25;11(1):e0146908. doi: 10.1371/journal.pone.0146908.
ecollection 2016.

assessment markers antimalarial drug resistance plasmodium falciparum
isolates pregnant women lagos, nigeria.

agomo co(1), oyibo wa(2), sutherland c(3), hallet r(3), oguike m(3).

author information: 
(1)malaria research laboratory, nigerian institute medical research, lagos,
nigeria.
(2)andi centre excellence malaria diagnosis/who/tdr/find malaria specimen 
bank site, college medicine, university lagos, idi-araba, lagos, nigeria.
(3)department immunology, london school tropical medicine hygiene,
london, united kingdom.

background: use antimalarial drugs prevention treatment major
strategy prevention malaria pregnancy. although
sulphadoxine-pyrimethamine (sp) currently recommended intermittent
preventive treatment malaria pregnancy nigeria, previously used
drugs prophylaxis chloroquine (cq) pyrimethamine accessible
as purchased counter. study describes markers of
absence presence resistance quinoline (pfcrt pfmdr 1) type 1
antifolate antimalarial medicines (pfdhfr).
methods: plasmodium falciparum-positive dried blood spots pregnant women
attending antenatal clinics first time current pregnancy were
investigated presence mutations codons 72-76 plasmodium
falciparum chloroquine resistance transporter (pfcrt) gene real time
polymerase chain reaction (pcr) using haplotype-specific probes. pcr followed 
sequence analysis used identify mutations codons 86, 184, 1034, 1042
and 1246 p. falciparum multi-drug resistance-1 (pfmdr1) gene; codons 16,
50, 51, 59, 108, 140 164 pfdhfr gene.
results: two haplotypes pfcrt (n = 54) observed: cvmnk 13(24.2%) and
cviet 41 (75.9%) samples. svmnt haplotype absent this
population. pfmdr1 (n = 28) haplotypes nysnd 15(53.6%), yysnd 5(17.9%), 
nfsnd 6(21.4%) yfsnd 2(7.1%). pfdhfr (n = 15) acncsvi 4(26.7%), 
acicnsvi 1(6.7%) acirnvi 10 (66.7%). rate occurrence pfcrt 76t,
pfdhfr108n, pfmdr186y 184f 75.9%, 73.3%, 25% 28.1% respectively. the
pfmdr1 86y associated low parasitaemia (median = 71 parasites/μl, p =
0.024) pfcrt 76t associated young maternal age (mean 24.1 ± 4.5
years; p = 0.006). median parasitaemia similar (p>0.05) wild and
mutant strains pfcrt 76, pfmdr1 184 pfdhfr 108. association
between gravidity gestational age women presence mutations in
the pfcrt, pfmdr1 pfdhfr genes (p>0.05).
conclusion: markers resistance chloroquine pyrimethamine high,
whereas cycloguanil-resistance marker present studied population. 
the low level mutations pfmdr1gene indicates likely efficacy of
amodiaquine malaria pregnancy.

doi: 10.1371/journal.pone.0146908 
pmcid: pmc4726598
pmid: 26808627  [indexed medline]

